Aarhus University logo / Aarhus Universitets logo
Funding and study opportunities have been made available from a variety of sources in Denmark, Finland, Norway and Sweden for researchers and students displaced from Ukraine. Read more.
The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.
The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.
The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.
Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice.
Where are they now? Meet MIMS alumnus Naresh Chandra and learn about how his time as a PhD student at MIMS prepared him for a position in pharma today.
A new study from the INTERVENE consortium has evaluated genome-wide risk prediction of common diseases across multiple ancestries in one million people.
The project deals optimization of peptides that can penetrate cell walls, so that biological drugs can get into cells.
On 6 April 2022, members of MIMS participated at an online meeting with the director and group leaders of the Vilnius University Life Sciences Center (VU LSC)-EMBL Partnership for Genome Editing Technologies.
Page 3 of 41.
